ICIG Announces New CordenPharma Management Team
6/3/2013 7:32:05 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
ICIG announced today changes in the management of CordenPharma, its pharmaceutical contract manufacturing business.
Effective June 1st, CordenPharma will operate two business groups, APIs and Drug Products. This occurs in response to strong growth and reflects the distinct nature of these businesses. The two businesses will continue to report to the President of CordenPharma, Dr. Wolfgang Niedermaier.
Help employers find you! Check out all the jobs and post your resume.